Interpretation and Discussion of Guidelines for Preventive Activities in General Practice: Bladder Cancer

doi:10.12114/j.issn.1007-9572.2025.0518

Chinese General Practice ›› 2026, Vol. 29 ›› Issue (18): 2450-2453.DOI: 10.12114/j.issn.1007-9572.2025.0518

• Guidelines·Consensus·Standards • Previous Articles

Interpretation and Discussion of Guidelines for Preventive Activities in General Practice: Bladder Cancer

1. Department of General Medicine, Huashan Hospital, Fudan University, Shanghai 200040, China
2. Department of Geriatrics, Huashan Hospital, Fudan University, Shanghai 200040, China
3. TianQiao and Chrissy Chen Institute Clinic Translational Research Center, Shanghai 200040, China

Received:2025-11-10 Revised:2026-03-30 Published:2026-06-20 Online:2026-05-21
Contact: HUANG Yanyan

澳大利亚全科医生学会《全科医学的预防活动指南》解读与讨论：膀胱癌的预防

1．200040　上海市，复旦大学附属华山医院全科医学科
2．200040　上海市，复旦大学附属华山医院老年医学科
3．200040　上海市，陈天桥脑健康研究院

通讯作者: 黄延焱
作者简介:
作者贡献：
范梅香负责论文初稿撰写与最终定稿；闫云云负责参考文献整理；黄延焱负责总体指导、论文最终版本审定，对论文负责。
基金资助:
上海市"医苑新星"青年医学人才培养资助计划(SHWSRS（2025）_071); 上海市浦东新区博士后科研创新资助项目(2023BSHKC-02); 上海市卫生健康委员会2025年度卫生行业临床研究专项(20254Y0009)

Abstract

Abstract:

As the world's tenth most prevalent cancer, bladder cancer imposes a substantial burden in China, exacerbated by rapid demographic aging and high rates of smoking and occupational exposure. The 10th edition of the Australian Guidelines for Preventive Activities in General Practice does not recommend bladder cancer screening for asymptomatic adults. Primary care practitioners are uniquely positioned to spearhead this transition by prioritizing primary prevention and lifestyle counseling. By focusing on high-risk cohorts and integrating early detection with standardized management, China can more effectively utilize healthcare resources and mitigate the long-term impact of the disease.

Key words: Bladder cancer, Preventive health services, Guidelines for Preventive Activities in General Practice, Interpretation and discussion, Screening, Diagnosis, Therapy

摘要：

膀胱癌作为全球第十大常见癌症，在我国呈现发病绝对数高、增长潜力大且老龄化负担重的特点，吸烟和职业暴露是其核心危险因素。澳大利亚全科医生学会《全科医学的预防活动指南》不建议对没有症状的成年人进行膀胱癌筛查。全科医生应发挥基层优势，以一级预防为重，强化控烟与职业防护和生活方式干预，实施高危人群的诊断性检查。总之，构建预防优先、靶向筛查、全程管理的综合体系，是实现医疗资源高效利用、缓解疾病负担的关键。

关键词: 膀胱癌, 预防卫生服务, 全科医学的预防活动指南, 解读和讨论, 筛查, 诊断, 治疗

CLC Number:

R 737.14

FAN Meixiang,YAN Yunyun,HUANG Yanyan. Interpretation and Discussion of Guidelines for Preventive Activities in General Practice: Bladder Cancer[J]. Chinese General Practice, 2026, 29(18): 2450-2453. DOI: 10.12114/j.issn.1007-9572.2025.0518.
范梅香,闫云云,黄延焱. 澳大利亚全科医生学会《全科医学的预防活动指南》解读与讨论：膀胱癌的预防[J]. 中国全科医学, 2026, 29(18): 2450-2453. DOI: 10.12114/j.issn.1007-9572.2025.0518.

References 26

[1]	FERLAY J, SOERJOMATARAM I, DIKSHIT R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012[J]. Int J Cancer, 2015, 136(5): E359-E386. DOI: 10.1002/ijc.29210.
[2]	JUBBER I, ONG S, BUKAVINA L, et al. Epidemiology of bladder cancer in 2023: a systematic review of risk factors[J]. Eur Urol, 2023, 84(2): 176-190. DOI: 10.1016/j.eururo.2023.03.029.
[3]	MOYER V A. Screening for bladder cancer: U.S. Preventive Services Task Force recommendation statement[J]. Ann Intern Med, 2011, 155(4): 246-251.
[4]	AUSTRALIA C. Bladder cancer statistics in Australia[EB/OL].(2025-10-31) [2026-01-10].
[5]	CHOU R, DANA T. Screening Adults for Bladder Cancer: A Review of the Evidence for the U.S. Preventive Services Task Force[M]. United States: Ann Intern Med, 2010.
[6]	HAN B, ZHENG R, ZENG H, et al. Cancer Incidence and Mortality in China, 2022[M]. Netherlands: J Natl Cancer Cent, 2024.
[7]	WELFARE A I O H A. Cancer Data in Australia [J]. (2025-10-08) [2026-01-10].
[8]	李贺珍, 郑荣寿, 杜灵彬, 等. 中国膀胱癌流行现状与趋势分析[J]. 中华肿瘤杂志, 2021, 43(3): 293-298.
[9]	ANTONI S, FERLAY J, SOERJOMATARAM I, et al. Bladder cancer incidence and mortality: a global overview and recent trends[J]. Eur Urol, 2017, 71(1): 96-108. DOI: 10.1016/j.eururo.2016.06.010.
[10]	KAMAT A M, HAHN N M, EFSTATHIOU J A, et al. Bladder cancer[J]. Lancet, 2016, 388(10061): 2796-2810.
[11]	PEDERSEN G L, ERIKSON M S, MOGENSEN K, et al. Outpatient photodynamic diagnosis-guided laser destruction of bladder tumors is as good as conventional inpatient photodynamic diagnosis-guided transurethral tumor resection in patients with recurrent intermediate-risk low-grade Ta bladder tumors. a prospective randomized noninferiority clinical trial[J]. Eur Urol, 2023, 83(2): 125-130.
[12]	LI F, ZHANG H H, WANG Y, et al. FGFBP1 as a potential biomarker predicting Bacillus Calmette-Guérin response in bladder cancer[J]. Front Immunol, 2022, 13: 954836.
[13]	中国肿瘤医院泌尿肿瘤协作组. 膀胱癌早诊早治专家共识(2024年版)[J]. 中国癌症杂志, 2024, 34(6): 607-618. DOI: 10.19401/j.cnki.1007-3639.2024.06.009.
[14]	LOBO N, AFFERI L, MOSCHINI M, et al. Epidemiology, screening, and prevention of bladder cancer[J]. Eur Urol Oncol, 2022, 5(6): 628-639. DOI: 10.1016/j.euo.2022.10.003.
[15]	BOTTEMAN M F, PASHOS C L, REDAELLI A, et al. The health economics of bladder cancer: a comprehensive review of the published literature[J]. Pharmacoeconomics, 2003, 21(18): 1315-1330. DOI: 10.1007/BF03262330.
[16]	JOYCE D D, SHARMA V, WILLIAMS S B. Cost-effectiveness and economic impact of bladder cancer management: an updated review of the literature[J]. Pharmacoeconomics, 2023, 41(7): 751-769.
[17]	CUMBERBATCH M G, ROTA M, CATTO J W, et al. The role of tobacco smoke in bladder and kidney carcinogenesis: a comparison of exposures and meta-analysis of incidence and mortality risks[J]. Eur Urol, 2016, 70(3): 458-466. DOI: 10.1016/j.eururo.2015.06.042.
[18]	POLESEL J, BOSETTI C, DI MASO M, et al. Duration and intensity of tobacco smoking and the risk of papillary and non-papillary transitional cell carcinoma of the bladder[J]. Cancer Causes Control, 2014, 25(9): 1151-1158. DOI: 10.1007/s10552-014-0416-0.
[19]	ERDURAK K, DUNDAR P E, OZYURT B C, et al. Smoking, occupation, history of selected diseases and bladder cancer risk in Manisa, Turkey[J]. Eur J Cancer Prev, 2014, 23(1): 58-61.
[20]	KRABBE L M, SVATEK R S, SHARIAT S F, et al. Bladder cancer risk: Use of the PLCO and NLST to identify a suitable screening cohort[J]. Urologic Oncol Semin Orig Investig, 2015, 33(2): 65.e19-65.e25. DOI: 10.1016/j.urolonc.2014.06.009.
[21]	GABRIEL U, LI L, BOLENZ C, et al. New insights into the influence of cigarette smoking on urothelial carcinogenesis: smoking-induced gene expression in tumor-free urothelium might discriminate muscle-invasive from nonmuscle-invasive urothelial bladder cancer[J]. Mol Carcinog, 2012, 51(11): 907-915. DOI: 10.1002/mc.20860.
[22]	XUE M, GUO W, ZHOU Y, et al. Age-sex-specific burden of urological cancers attributable to risk factors in china and its provinces, 1990-2021, and forecasts with scenarios simulation: a Systematic analysis for the Global Burden of Disease Study 2021[M]. England: Lancet Reg Health West Pac, 2025.
[23]	WESTHOFF E, MARIA DE OLIVEIRA-NEUMAYER J, ABEN K K, et al. Low awareness of risk factors among bladder cancer survivors: New evidence and a literature overview[J]. Eur J Cancer, 2016, 60: 136-145. DOI: 10.1016/j.ejca.2016.03.071.
[24]	NICOLAU C, BUNESCH L, PERI L, et al. Accuracy of contrast-enhanced ultrasound in the detection of bladder cancer[J]. Br J Radiol, 2011, 84(1008): 1091-1099. DOI: 10.1259/bjr/43400531.
[25]	DATTA S N, ALLEN G M, EVANS R, et al. Urinary tract ultrasonography in the evaluation of haematuria—a report of over 1, 000 cases[J]. Ann R Coll Surg Engl, 2002, 84(3): 203-205.
[26]	VOLLSET S E, GOREN E, YUAN C W, et al. Fertility, mortality, migration, and population scenarios for 195 countries and territories from 2017 to 2100: a forecasting analysis for the Global Burden of Disease Study[J]. Lancet, 2020, 396(10258): 1285-1306.

Interpretation and Discussion of Guidelines for Preventive Activities in General Practice: Bladder Cancer

澳大利亚全科医生学会《全科医学的预防活动指南》解读与讨论：膀胱癌的预防

RichHTML

PDF

Knowledge

Abstract

Cite this article

share this article

References 26

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	General Practice Branch of Cross-straits Medicine Exchange Association, General Practice Branch of Zhejiang Medical Association, General Undifferentiated Disease Professional Committee of Zhejiang Society of Mathematical Medicine, Chinese Geriatrics Society. Expert Consensus on the Diagnosis, Treatment, and Management of Numbness (2025) [J]. Chinese General Practice, 2026, 29(18): 2433-2449.
[2]	LUAN Xiaoqing, SUN Jingjing, LI Xiaoling, WANG Manxia. Research Progress on Potential Biomarkers of Neuromyelitis Optica Spectrum Disorder [J]. Chinese General Practice, 2026, 29(17): 2418-2424.
[3]	ZHENG Zelu, ZHOU Jun, LIANG Zhi, WANG Xuehui, XU Feng, LI Oujing, XIAO Hong, LIU Xiaoyu, YANG Qingmei, ZHANG Mei, LIN Na, MI Baohong, CHEN Weiheng. Comorbidity Profiles and Treatment Patterns of Osteoarthritis Patients: a Cross-sectional Study Based on Community Medical Records [J]. Chinese General Practice, 2026, 29(16): 2205-2213.
[4]	GUO Jiao, ZHANG Gaojing, LIU Xincan. Quality Evaluation of TCM Clinical Practice Guidelines/Consensus: Based on Two Guideline Evaluation Tools [J]. Chinese General Practice, 2026, 29(15): 2100-2106.
[5]	YAO Dingye, LUO Guiping, SUN Junsheng, LI Hui. Research Progress on Identifying Bipolar Ⅱ Disorder and Depressive Disorder in Primary Care [J]. Chinese General Practice, 2026, 29(15): 2092-2099.
[6]	HE Linqin, LI Xiaodong, LIU Hongpeng, CHEN Qipeng, TANG Zonghan, REN Xaingqian, SONG Hanbing. Acupotomy Inhibits Knee Osteoarthritis Through Activating A3AR to Suppress Chondrocyte Pyroptosis Via the Wnt/β-catenin Signaling Pathway [J]. Chinese General Practice, 2026, 29(15): 2056-2066.
[7]	Nephrology Branch of China Association of Chinese Medicine, Nephrology Committee of Guangdong Provincial Association of Chinese Medicine, SU Peiling, YANG Lihong, BAO Kun. Diagnosis and Treatment Guideline of Integrated Traditional Chinese and Western Medicine for Idiopathic Membranous Nephropathy (2025) [J]. Chinese General Practice, 2026, 29(15): 1953-1970.
[8]	XIONG Siyu, LU Bing, JIANG Wenhong, YU Tingting. Study on the Relationship between Fructose-1, 6-Bisphosphate Aldolase A Expression before and after Targeted Drug Resistance in Lung Adenocarcinoma and Patient Prognosis [J]. Chinese General Practice, 2026, 29(14): 1883-1889.
[9]	JIANG Nan, YANG Wei. A Prospective Randomized Controlled Trial on the Effects of Press Needle Therapy on Improving Bowel Movements in Patients with Chronic Constipation and Mixed Hemorrhoids Following Hemorrhoidectomy Based on Regulating Intestinal Nerve Function [J]. Chinese General Practice, 2026, 29(14): 1849-1857.
[10]	ZHAN Li, HENG Zhaoyang, HE Liangyu, ZHAO Jie, CHEN Jie, XING Jinshan. Efficacy and Safety of CAR-T Therapy Targeting the B Cell Maturation Antigen on Relapsed/Refractory Multiple Myeloma in Chinese People: a Meta-analysis [J]. Chinese General Practice, 2026, 29(14): 1921-1930.
[11]	YAN Wenxin, LIU Jue, LIANG Wannian. Perspectives on Key Issues of the General Practice Discipline Development in China [J]. Chinese General Practice, 2026, 29(13): 1649-1653.
[12]	YU Xuefang, ZHU Min, MA Qinglin, TAN Shenlang, WU Zixing, JIANG Wei. Clinical Efficacy of Chaihu Longgu Muli Decoction Combined with Cognitive Behavioral Therapy in the Treatment of Acute Insomnia of Liver Qi Stagnation with Fire Transformation Type [J]. Chinese General Practice, 2026, 29(13): 1666-1672.
[13]	ZHANG Hanzhi, JIN Hua, MA Le, SHI Ling, CHEN Chen, HUAN Hongmei, YU Dehua. Analysis of the Quality of Diagnosis and Treatment of Osteoporosis in Shanghai Community Health Service Institutions [J]. Chinese General Practice, 2026, 29(12): 1548-1557.
[14]	ZHANG Han, ZHANG Hua, CAI Genshen, LIAN Dongbo, ZHANG Jing. Construction of Weight Loss Clinic in Grassroots Medical Institutions and Typical Case Studies [J]. Chinese General Practice, 2026, 29(12): 1520-1524.
[15]	HE Zhiguang, QIU Shanjiao, CHEN Zhang, LI Anchun, HUANG Wenjing. Interpretation and Discussion of the RACGP Guidelines for Preventive Activities in General Practice: Screening for Weight Issues and Preventive Strategies [J]. Chinese General Practice, 2026, 29(12): 1505-1510.